Trastuzumab in the management of early and advanced stage breast cancer.
about
The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsCardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and ManagementA phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy.Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.Precision glycocalyx editing as a strategy for cancer immunotherapy.Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerImproved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer.Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization.The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance.Cardiotoxicity of Anticancer Therapeutics.Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.Effectiveness of trastuzumab as adjuvant therapy in patients with early stage breast cancer: A systematic review and meta-analysis.
P2860
Q28066752-DB8F6187-D751-4E5B-AFD3-781599CEE790Q28068290-388AEDDE-DE1C-4B3D-8C1D-7C1C31CD88CBQ33410791-39D5E9D1-8D03-4125-A989-AE800193A13FQ33823065-5D3F9240-141E-40B8-A16E-0EF490B02C42Q36791562-16CAF4D3-B1B9-4D8F-9AA5-8E46AB69D8DEQ37264064-B942B7D7-AEBA-4DBF-98E7-18F96895FE25Q37588298-EBE4F9A3-C861-4A55-95C6-BE1F59D3B50BQ42070603-E4A7644E-CB39-4663-B728-F075AECED08BQ42366884-4EF4A7A4-A6C5-4BC9-A2BC-2800089353FFQ47415861-08C787EC-BE8C-4058-A08B-3FC6C8A2C56BQ50326869-C11C5910-DC0F-46A0-81F2-DC8556ACD462Q52343895-62432D92-F35D-4B12-BA04-1F24659F3F55Q55314739-4617607E-AD60-430E-A41E-07244C9F4A67
P2860
Trastuzumab in the management of early and advanced stage breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trastuzumab in the management of early and advanced stage breast cancer.
@en
Trastuzumab in the management of early and advanced stage breast cancer.
@nl
type
label
Trastuzumab in the management of early and advanced stage breast cancer.
@en
Trastuzumab in the management of early and advanced stage breast cancer.
@nl
prefLabel
Trastuzumab in the management of early and advanced stage breast cancer.
@en
Trastuzumab in the management of early and advanced stage breast cancer.
@nl
P2093
P2860
P1476
Trastuzumab in the management of early and advanced stage breast cancer
@en
P2093
Catharina Wenzel
Guenther G Steger
Rupert Bartsch
P2860
P577
2007-03-01T00:00:00Z